Newsroom

Latest News

PMI U.S. is Investing in America

PMI U.S. CEO Stacey Kennedy discusses the company’s mission to help smokers switch to better alternatives and investing in American workers and innovation.

FDA Authorizes All ZYN Nicotine Pouch Products Currently Marketed by Swedish Match in the U.S.

FDA’s science-based decision makes ZYN the first authorized nicotine pouch product and affirms that ZYN nicotine pouches are a better alternative for adults who smoke or use other traditional tobacco products.

FDA Authorizes Marketing of IQOS as a Modified Risk Tobacco Product

The FDA authorized the marketing of IQOS, an electrically heated tobacco system, as a modified risk tobacco product (MRTP). In doing so, the agency found that an IQOS exposure modification order is appropriate to promote the public health.

In the News

New PMI U.S. survey signals a shift to an “Era of Pragmatic Philanthropy,” as public seeks community-first leadership.

 

Jun 11, 2025

A new survey has found that 47% of U.S. healthcare practitioners—rising to 59% among medical professionals who indicate that half or more of their patients smoke cigarettes—mistakenly believe nicotine is a carcinogen.

 

May 21, 2025

New report highlights the often-overlooked challenge of sustained employment for military spouses.

 

May 14, 2025

PMI U.S. hosted experts to help address common challenges that military families face.

 

May 5, 2025

PMI U.S. announced the introduction of its IQOS heated tobacco system in the greater Fort Lauderdale area, giving residents 21+ who consume nicotine the opportunity to join a waiting list to be among the first to try this innovative product.

 

May 2, 2025

Authorized by the U.S. Food and Drug Administration as a modified risk tobacco product, IQOS complements PMI U.S. portfolio—alongside ZYN nicotine pouches—to provide adult nicotine consumers 21+ with more smoke-free choices.

 

Apr 30, 2025 

More than 28 million American adults still smoke cigarettes, including 900,000 Tennesseans.

 

February 25, 2025

Independent survey shows most people strongly believe in innovation’s potential to address the most critical issues in the next 10–20 years.

 

January 22, 2025

U.S. Surgeon recently released a report entitled on the disproportionate impact cigarette smoking has on certain communities and the associated public health implications.

 

December 23, 2024

Globally, PMI has invested more than $12.5 billion to develop satisfying smoke-free products to help people move away from more harmful forms of tobacco.

 

December 5, 2024

Philip Morris International affiliate, Swedish Match, earned first-ever FDA authorization for a modified risk marketing claim and now is the first to achieve an FDA renewal.

 

November 12, 2024

Recent reports that youth e-cigarette use has fallen to its lowest level in a decade mark a major victory for public health.

 

October 7, 2024

To help the over 28 million Americans who smoke but don’t quit, leaders in Washington should make declaring independence from smoking a policy priority.

 

July 10, 2024

Experts from Swedish Match USA, Inc., an affiliate of Philip Morris International Inc. presented to the Tobacco Products Scientific Advisory Committee (TPSAC) on General Snus MRTP renewal.

 

July 1, 2024

People have long put their health—even their lives—at risk with behaviors and actions that aren't good for them. 

 

June 12, 2023

Smoking remains the No. 1 cause of preventable death in the U.S. today, according to CDC public health data. 

 

May 25, 2023

Nicotine is addictive and not risk-free, but its role in smoking-related diseases is often misunderstood. 

 

May 23, 2023

When it comes to reducing smoking, there are three things the FDA should do immediately to connect with and motivate adult smokers.

 

April 24, 2023

If you want people to stop smoking cigarettes, we need these companies to stop selling cigarettes.

 

December 15, 2022

Media Contacts

For press inquiries, please reach out to

corporatecommunications.us@smpmi.com